Funding-Gerber
Foundation Seeks Proposals for Pediatric Research Projects; June 1, 2014
Agency
Gerber
Foundation
Description
The Gerber
Foundation is accepting concept papers for health and/or
nutrition-related research on issues affecting infants and young children. Of
particular interest are applied research projects
focused on reducing the incidence of serious neonatal and early childhood
illnesses, or improving cognitive, social, and emotional aspects of
development.
The
foundation awards pediatric research grants through two programs, a Research
Award and a Novice Research Grant. Both grants support research designed to
improve health, nutrition, and/or developmental outcomes for infants from
before birth and children up to age 3. Projects may include etiologic
mechanisms of disease; new, improved, or less invasive diagnostic procedures;
reduction or elimination of side effects; alleviation of symptoms; new,
improved, or less invasive therapies, care, or treatments; dosage or dosing
requirements or mechanisms for drugs, nutrient supplementation, or other
therapeutic measures (under or overdosing); and preventative measures.
Research
Awards of up to $300,000 will be made to organizations recognized as tax exempt
under Section 501(c)(3) of the Internal Revenue Code.
In addition, organizations must not be private foundations as defined by
Internal Revenue Code Section 509.
Novice
Research Grants of up to $20,000 per project will be awarded to physicians as
well as candidates for Ph.D. and PharmD degrees who
are in a residency or fellowship training program and are no more than one year
post training. The Novice Research Grant program also provides up to $2,000 to
cover travel and attendance costs for one conference so that the awarded can
report findings from the project during the grant period. Novice Research
grantees must have an assigned mentor for the project as well as a current
development plan and must not have received a K award from the National
Institutes of Health. The qualifications and experience of the mentor will be
an evaluation consideration.
Priority is
given to projects offering a substantial promise of meaningful advances in
prevention and treatment of diseases and those with broad applicability to the
general population on a regional or national level.
Closing
Date:
June 1, 2014 (Concept
Papers)
Link
to Full Announcement